Boardroom Alpha
Boardroom Alpha
BVFL · Current Report (Form 8-K) · Filed February 23, 2026

Bv Financial Inc — Current Report (Form 8-K)

Form
8-K
Filed
February 23, 2026
Period
Feb 20, 2026
Ticker
BVFL
Accession
0001193125-26-064120
Boardroom Alpha · Filing insights

BV Financial dismisses Forvis Mazars; Crowe to audit 2026 year; no disagreements or reportable events.

Auditor dismissed
About Bv Financial Inc
Market cap
$171M
1Y TSR
+33.1%
Board grade
B
Sector
Financial Services
CEO
Timothy L Prindle
Last annual meeting: May 7, 2026 · View full Bv Financial Inc profile →
8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 20, 2026

 

 

BV FINANCIAL, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Maryland

001-36094

14-1920944

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

7114 North Point Blvd.

 

Baltimore, Maryland

 

21219

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 410 477-5000

 

BV FINANCIAL, INC.

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

BVFL

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

{ DOCPROPERTY "CUS_DocIDChunk0" 4924-1300-2890-v1}


Item 4.01 Changes in Registrant’s Certifying Accountant.

 

On February 20, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of BV Financial, Inc. (the “Company”) approved the dismissal of Forvis Mazars, LLP (“Forvis Mazars”) as the Company's independent registered public accounting firm effective upon completion by Forvis Mazars of its audit of the Company's consolidated financial statements for the fiscal year ended December 31, 2025 and the filing of the Company's 2025 Annual Report on Form 10-K (the "Effective Date"). On February 20, 2026, the Audit Committee notified Forvis Mazars of the dismissal as of the Effective Date. Concurrently, the Audit Committee approved the engagement of Crowe LLP (“Crowe”) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2026, effective as of the Effect Date. The Company’s formal engagement of Crowe remains subject to the completion of Crowe’s standard client acceptance procedures and execution of an engagement letter.

 

Forvis Mazars' reports on the Company's consolidated financial statements as of and for the fiscal years ended December 31, 2023 and December 31, 2024 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles.

 

During the fiscal years ended December 31, 2023 and December 31, 2024, and the subsequent interim period through the date of this Current Report on Form 8-K, there were: (i) no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K) with Forvis Mazars on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Forvis Mazars, would have caused it to make reference to the subject matter thereof in connection with its reports on the consolidated financial statements for such years, and (ii) no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K).

 

The Company has provided Forvis Mazars with a copy of the disclosures made in this Current Report on Form 8-K and has requested that Forvis Mazars furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of Forvis Mazars' letter, dated February 23, 2026, is filed as Exhibit 16.1 to this Current Report on Form 8-K.

 

During the fiscal years ended December 31, 2023 and December 31, 2024 and the subsequent interim period through the date of this Current Report on Form 8-K, neither the Company nor anyone acting on its behalf has consulted with Crowe regarding: (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided to the Company that Crowe concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue; (ii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions; or (iii) any reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

Exhibit No. Description

 

16.1 Letter from Forvis Mazars to the Securities and Exchange Commission dated February 23, 2026


{ DOCPROPERTY "CUS_DocIDChunk0" 4924-1300-2890-v1}


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BV Financial, Inc.

 

 

 

 

Date:

February 23, 2026

By:

 /s/ Timothy L. Prindle

 

 

 

 President and Chief Executive Officer

 

{ DOCPROPERTY "CUS_DocIDChunk0" 4924-1300-2890-v1}


From this filing to the watchlist

Catch material events the day they file.

Boardroom Alpha's monitors flag CEO/CFO transitions, restatements, going-concern risk, auditor changes, and 8-K events the day they hit EDGAR — across 6,000+ U.S. public companies. Daily digest by watchlist, API-accessible.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Bv Financial Inc (BVFL)

Reference

Frequently asked questions

When did Bv Financial Inc file this 8-K?
Bv Financial Inc (BVFL) filed this Current Report (Form 8-K) with the SEC on February 23, 2026. The accession number assigned by EDGAR is 0001193125-26-064120.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
BV Financial dismisses Forvis Mazars; Crowe to audit 2026 year; no disagreements or reportable events. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Auditor dismissed". It appears above the filing body as a labeled pill.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Bv Financial Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Bv Financial Inc has filed under CIK 1302387, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer